Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production
Open Access
- 11 September 2014
- journal article
- research article
- Published by Springer Nature in Hypertension Research
- Vol. 38 (1) , 21-29
Abstract
Macrophages have an important role in the pathogenesis of hypertension and associated end-organ damage via the activation of the Toll-like receptors, such as Toll-like receptor-4 (TLR4). Accumulating evidence suggests that the angiotensin AT2 receptor (AT2R) has a protective role in pathological conditions involving inflammation and tissue injury. We have recently shown that AT2R stimulation is renoprotective, which occurs in part via increased levels of anti-inflammatory interleukin-10 (IL-10) production in renal epithelial cells; however, the role of AT2R in the inflammatory activity of macrophages is not known. The present study was designed to investigate whether AT2R activation stimulates an anti-inflammatory response in TLR4-induced inflammation. The effects of the anti-inflammatory mechanisms that occurred following pre-treatment with the AT2R agonist Compound 21 (C21) (1 μmol ml−1) on the cytokine profiles of THP-1 macrophages after activation by lipopolysaccharide (LPS) (1 μg ml−1) were studied. The AT2R agonist dose-dependently attenuated LPS-induced tumor necrosis factor-α (TNF-α) and IL-6 production but increased IL-10 production. IL-10 was critical for the anti-inflammatory effects of AT2R stimulation because the IL-10-neutralizing antibody dose-dependently abolished the AT2R-mediated decrease in TNF-α levels. Further, enhanced IL-10 levels were associated with a sustained, selective increase in the phosphorylation of extracellular signal-regulated kinase (ERK1/2) but not p38 mitogen-activated protein kinase (MAPK). Blocking the activation of ERK1/2 before C21 pre-treatment completely abrogated this increased IL-10 production in response to the AT2R agonist C21, while there was a partial reduction in IL-10 levels following the inhibition of p38. We conclude that AT2R stimulation exerts a novel anti-inflammatory response in THP-1 macrophages via enhanced IL-10 production as a result of sustained, selective ERK1/2 phosphorylation, which may have protective roles in hypertension and associated tissue injury.Keywords
This publication has 78 references indexed in Scilit:
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Angiotensin II Type-2 Receptors Modulate Inflammation Through Signal Transducer and Activator of Transcription Proteins 3 Phosphorylation and TNFα ProductionJournal of Interferon & Cytokine Research, 2011
- Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesityAmerican Journal of Physiology-Renal Physiology, 2011
- Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker ratsAmerican Journal of Physiology-Renal Physiology, 2011
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular HypertensionHypertension, 2011
- Stimulation of angiotensin AT2receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive ratsBritish Journal of Pharmacology, 2010
- Candesartan reduces the innate immune response to lipopolysaccharide in human monocytesJournal Of Hypertension, 2009
- TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cellsJournal of Experimental Medicine, 2009
- Angiotensin AT1 receptor antagonists exert anti‐inflammatory effects in spontaneously hypertensive ratsBritish Journal of Pharmacology, 2007
- LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanismsRespiratory Research, 2007